Roche Holding AG (RHHBY) News
Follow Roche Holding AG (RHHBY) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 15 public stories across 15 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Roche Says Divarasib Cut Death Risk 44% in Phase III Lung Cancer Trial
Roche reported Phase III Krascendo 1 results showing investigational divarasib reduced the risk of death by 44% versus existing KRAS G12C inhibitors.
EQUITY | Oct 26, 2026, 08:53 AM UTC
M
Genentech Reports Phase III Divarasib Efficacy Results in Lung Cancer
Genentech said its Phase III KRASCENDO 1 study found investigational divarasib more efficacious than current standard of care in previously treated KRAS G12C-mutated lung cancer.
EQUITY | Oct 25, 2026, 03:30 PM UTC
L
Genentech’s Fenebrutinib Is the First BTK Inhibitor to Receive U.S. FDA Filing Acceptance in Both Relapsing and Primary Progressive Multiple Sclerosis
Genentech, a member of the Roche Group (SIX:RO, ROP; OTC:RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) under priority review for fenebrutin
REGULATION | Sep 30, 2026, 05:00 AM UTC
L
Genentech Breaks Ground on $750 Million Manufacturing Expansion in Hillsboro, Oregon
Genentech, a member of the Roche Group (SIX:RO, ROP; OTC:RHHBY), today broke ground on a $750 million expansion of its manufacturing facility in Hillsboro, Oregon, advancing plans announced in August to increase capacity
NEWS | Sep 28, 2026, 10:00 PM UTC
L
RBC starts EU pharma coverage with Outperform ratings for AstraZeneca, Roche
RBC Capital Markets launched EU pharma coverage: Outperform for AstraZeneca and Roche, and Sector Perform for Sanofi, Novartis and GSK.
EQUITY | Sep 09, 2026, 02:43 PM UTC
L
Quest Diagnostics to add Roche ptau217, launch Ad-detect test
Quest Diagnostics says it will incorporate Roche ptau217 testing into Ad-detect panels in 2027 and launch a new Ad-detect multi-biomarker lab test nationwide at month-end.
EQUITY | Aug 24, 2026, 11:29 AM UTC
L
Roche receives FDA 510(k) clearance for cobas BV/CV assay
Roche announced that it...
EQUITY | Jul 24, 2026, 12:32 PM UTC
L
Roche confirms FY26 outlook
Roche expects an increase...
EQUITY | Jul 23, 2026, 10:12 AM UTC
H
Trump Trade: U.S. to impose 100% tariff on imported generic drugs
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled. IMPORTED GENERIC DRUGS: U.S.
GEOPOLITICS | Jul 22, 2026, 02:08 PM UTC
H
Trump to set 100% tariff on generic drugs brought into U.S. starting in 2028
U.S. President Donald...
GEOPOLITICS | Jul 21, 2026, 11:03 PM UTC
L
Genentech granted priority review for Gazyva sBLA by FDA
Genentech, a member of...
REGULATION | Jul 15, 2026, 09:38 AM UTC
L
Roche's Divarasib Shows Statistically Significant Progression-Free And Overall Survival Gains Versus Sotorasib Or Adagrasib In NSCLC Study
Phase III (Krascendo 1) demonstrates best-in-class potential for patients with previously treated advanced KRAS G12C non-small cell lung cancer Divarasib showed clinically meaningful improvements in progression-free surv
EQUITY | Jul 02, 2026, 06:23 AM UTC
M
Roche's Genentech Receives FDA Priority Review For Enspryng As First At-Home Subcutaneous Treatment For Thyroid Eye Disease
The filing application is based on improvements seen across key efficacy endpoints from the global Phase III SatraGO-1 and SatraGO-2 studies, including proptosis (bulging eyes) and diplopia (double vision) in active TED
REGULATION | Jun 30, 2026, 06:55 AM UTC
H
EU Eases Deportation Rules
The European Parliament has approved a major migration overhaul to simplify deportation procedures and respect fundamental rights and international law.
GEOPOLITICS | Jun 23, 2026, 07:29 PM UTC
H
GLP-1 Drugs Disrupt Food Chain
GLP-1 medications are changing consumer behavior, reducing food consumption and increasing demand for nutrient-dense products, affecting various industries including food, pharmaceuticals, and airlines.
EQUITY | Jun 22, 2026, 11:18 AM UTC